20 20 GeneSystems, based in Rockville, MD, is a leading life science company specializing in modernizing clinical lab testing through the use of machine learning and real-world data. Their flagship product, OneTest for Cancer, combines the results of six cancer biomarker tests with personal health data and an artificial intelligence algorithm to provide a probability score for various types of cancers, offering a comprehensive and efficient screening solution. Additionally, the company has gained recognition for its Covid-19 testing services, serving customers in the Mid-Atlantic Region and being selected as the laboratory of choice by Montgomery County, Maryland.
With a strong focus on innovation and market demand, 20 20 GeneSystems has experienced remarkable success, raising significant capital through equity crowdfunding and reporting record sales. Their dedication to cancer screening and viral testing has positioned them as one of the fastest-growing privately-owned companies in the nation, earning them a spot on INC's 5000 list. Through their commitment to reducing cancer deaths worldwide and adapting to challenging times, 20 20 GeneSystems continues to make strides in the field of clinical lab testing.
Generated from the website